IL-17 Antibody

ProSci
Product Code: PSI-4887
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-4887-0.02mg0.02mg£150.00
Quantity:
PSI-4887-0.1mg0.1mg£449.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Western Blot (WB)

Images

1 / 8
<strong>Figure 1 Western Blot Validation with Recombinant Protein</strong><br>
Loading: 30 ng of human IL-17 recombinant protein per lane.
Antibodies: IL-17 4887, 1h incubation at RT  in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Lane 1: 0.125 μg/mL
Lane 2: 0.25 μg/mL
Lane 3: 0.5 μg/mL
2 / 8
<strong>Figure 2 Western Blot Validation with Human Spleen </strong><br>
Loading: 10 μg of lysates per lane.
Antibodies: IL-17 4887, 1h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Exposure: 1 min
Lane 1: 1 μg/mL 
Lane 2: 2 μg/mL
3 / 8
<strong>Figure 3 Immunohistochemistry Validation of IL-17 in Human Lymph Node </strong><br> 
Immunohistochemical analysis of paraffin-embedded human lymph node tissue using anti-IL-17 antibody (4887) at 1 μg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
4 / 8
<strong>Figure 4 Immunofluorescence Validation of IL-17 in Mouse Heart Tissue</strong><br>
Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse heart issue labeling IL-17 with 4887 at 10 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
5 / 8
<strong>Figure 5 Immunofluorescence Validation of IL-17 in Mouse A-20 Cells</strong><br>
Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse A-20 Cells labeling IL-17 with 4887 at 5 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
6 / 8
<strong>Figure 6 Immunofluorescence Validation of IL-17 in Mouse Thymus Tissue</strong><br>
Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse thymus tissue labeling IL-17 with 4887 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).
7 / 8
<strong>Figure 7 Immunohistochemistry Validation of IL-17 in Mouse Colon Tissue </strong><br> 
Immunohistochemical analysis of paraffin-embedded mouse colon tissue using anti-IL-17 antibody (4887) at 2 μg/mL. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚ C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
8 / 8
<strong>Figure 8 Immunohistochemistry Validation of IL-17 in Human Tonsil Tissue </strong><br> 
Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-IL-17 antibody (4887) at 5 μg/mL. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚ C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

<strong>Figure 1 Western Blot Validation with Recombinant Protein</strong><br>
Loading: 30 ng of human IL-17 recombinant protein per lane.
Antibodies: IL-17 4887, 1h incubation at RT  in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Lane 1: 0.125 μg/mL
Lane 2: 0.25 μg/mL
Lane 3: 0.5 μg/mL
<strong>Figure 2 Western Blot Validation with Human Spleen </strong><br>
Loading: 10 μg of lysates per lane.
Antibodies: IL-17 4887, 1h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Exposure: 1 min
Lane 1: 1 μg/mL 
Lane 2: 2 μg/mL
<strong>Figure 3 Immunohistochemistry Validation of IL-17 in Human Lymph Node </strong><br> 
Immunohistochemical analysis of paraffin-embedded human lymph node tissue using anti-IL-17 antibody (4887) at 1 μg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
<strong>Figure 4 Immunofluorescence Validation of IL-17 in Mouse Heart Tissue</strong><br>
Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse heart issue labeling IL-17 with 4887 at 10 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
<strong>Figure 5 Immunofluorescence Validation of IL-17 in Mouse A-20 Cells</strong><br>
Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse A-20 Cells labeling IL-17 with 4887 at 5 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
<strong>Figure 6 Immunofluorescence Validation of IL-17 in Mouse Thymus Tissue</strong><br>
Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse thymus tissue labeling IL-17 with 4887 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).
<strong>Figure 7 Immunohistochemistry Validation of IL-17 in Mouse Colon Tissue </strong><br> 
Immunohistochemical analysis of paraffin-embedded mouse colon tissue using anti-IL-17 antibody (4887) at 2 μg/mL. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚ C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
<strong>Figure 8 Immunohistochemistry Validation of IL-17 in Human Tonsil Tissue </strong><br> 
Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-IL-17 antibody (4887) at 5 μg/mL. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4˚ C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Further Information

Additional Names:
IL-17 Antibody: IL17, CTLA8, IL-17, IL-17A, IL17, Interleukin-17A, Cytotoxic T-lymphocyte-associated antigen 8
Application Note:
WB: 0.125-2 μg/mL; IF: 5-20 μg/mL; IHC: 1-5 μg/mL .

Antibody validated: Western Blot in human samples; Immunofluorescence in mouse samples; Immunohistochemistry in human and mouse samples. All other applications and species not yet tested.
Background:
IL-17 Antibody: Interleukin 17 (IL-17) is a family of pro-inflammatory cytokines produced by activated T cells and is thought to have a major role in the initiation and perpetuation of rheumatoid arthritis. IL-17 regulates the activities of NF-κB and mitogen-activated protein kinases such as ERK and JNK. In addition, IL-17 stimulates the expression of IL-6 and cyclooxygenase-2 and enhances the production of nitric oxide. IL-17-producing T helper cells (TH-17 cells) have been the subject of much attention due to the importance of IL-17 in the pathogenesis of autoimmune inflammation. Because of its role in autoimmune diseases, it is thought that targeting the production and action of IL-17 would be beneficial therapeutically in these diseases.
Background References:
  • Miossec. Curr. Opin. Rheumatol.2000; 12:181-5.
  • Paunovic et al. Rheumatol.2008; 47:771-6.
  • Steinman. Nat. Med.2007; 13:139-145.
Buffer:
IL-17 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Homology:
Predicted species reactivity based on immunogen sequence: Bovine: (84%), Rat: (81%), Pig: (74%)
Immunogen:
Anti-IL-17 antibody (4887) was raised against a peptide corresponding to 16 amino acids near the center of mature human IL-17.

The immunogen is located within amino acids 50-100 of IL-17.
ISOFORMS:
Human IL-17 has only one isoform (155aa, 17.5kD). Mouse IL-17 has one isoform (158aa, 17.5kD) and Rat IL-17 also has one isoform (150aa, 16.9kD). 4887 can detect human, mouse and rat IL-17.
NCBI Gene ID #:
3605
NCBI Official Name:
interleukin 17A
NCBI Official Symbol:
IL17A
NCBI Organism:
Homo sapiens
Physical State:
Liquid
PREDICTED MOLECULAR WEIGHT:
Predicted: 17.5kD

Observed: 18 kDa
Protein Accession #:
NP_002181
Protein GI Number:
4504651
Purification:
IL-17 Antibody is affinity chromatography purified via peptide column.
Research Area:
Signal Transduction
Swissprot #:
Q16552
User NOte:
Optimal dilutions for each application to be determined by the researcher.
VALIDATION:

Recombinant Protein Test (Figure 1): Anit-IL-17 antibodies (4887) detected human IL-17 recombinant protein at different concentrations

Related Products

Product NameProduct CodeSupplier 
IL-17 PeptidePSI-4887PProSci Summary Details